Effect on Immune function and pulmonary function of montelukast sodium combined with azithromycin in children with mycoplasma pneumonia

Effect on Immune function and pulmonary function of montelukast sodium combined with azithromycin in children with mycoplasma pneumonia

Objective: To observe the effect on Immune function and pulmonary function of montelukast sodium combined with azithromycin in children with mycoplasma pneumonia. Methods: A total of 100 cases of MPP children according to the inclusion sequence were divided into observation group and control grou...

Full description

Bibliographic Details
Main Authors:	Yu-Ping Xia, Yuan Fangu
Format:	Article
Language:	English
Published:	Editorial Board of Journal of Hainan Medical University 2016-09-01
Series:	Journal of Hainan Medical University
Subjects:	Children Mycoplasma pneumonia Azithromycin Montelukast sodium Immune function Pulmonary function
Online Access:	http://www.hnykdxxb.com/PDF/201618/12.pdf

Similar Items

Therapeutic effect of montelukast sodium + methylprednisolone + azithromycin therapy for patients with mycoplasma pneumonia
by: Hong-Tu Wu, et al.
Published: (2018-09-01)

Effect of budesonide inhalation combined with azithromycin on pulmonary function, serum inflammatory factors and immune function of children with mycoplasma pneumonia
by: Yi-Lin Tan, et al.
Published: (2016-11-01)

Effect of Yanhuning in combined with azithromycin on the inflammatory cytokines and immunological function in children with mycoplasma pneumonia
by: Guo Hui, et al.
Published: (2017-10-01)

Effect of azithromycin, montelukast combined with pulmicort respulas therapy on the degree of inflammation and lung function in children with mycoplasma pneumonia
by: Jian-mei Zhang, et al.
Published: (2016-09-01)

Effect of anisodamine injection-assisted azithromycin sequential therapy on serum indexes in children with mycoplasma pneumonia
by: Huan Zhang
Published: (2016-02-01)

Effect of azithromycin combined with terbutaline on the infection and systemic conditions in children with mycoplasma pneumonia
by: Ren-Hui Tang
Published: (2017-08-01)

Effect of azithromycin combined with fat-soluble vitamin on serum inflammatory cytokines and chemokines as well as lung function in children with mycoplasma pneumonia
by: Ming-Guang Yang1, et al.
Published: (2017-04-01)

Control of a Mycoplasma pneumoniae Outbreak in an Institutional Setting Using Azithromycin Prophylaxis
by: Michael Gdalevich, et al.
Published: (2018-01-01)

Effect of azithromycin combined with licorzinc therapy on inflammatory response and immune response in children with mycoplasma pneumonia
by: Qiao-Li Chai
Published: (2017-07-01)

Role of Probiotics in Mycoplasma pneumoniae Pneumonia in Children: A Short-Term Pilot Project
by: Zongxin Ling, et al.
Published: (2019-01-01)

Effect of Montelukast sodium combined with Budesonide aerosol on airway function and T lymphocytes in asthmatic children
by: Jin, W., et al.
Published: (2022)

Acute saddle pulmonary embolism: A rare complication of mycoplasma pneumonia
by: Farrah Chilet, et al.
Published: (2020-01-01)

Effects of montelukast sodium combined with pidotimod on acute phase protein and immune function in children with acute bronchitis
by: Jing Wang, et al.
Published: (2017-08-01)

Effect of azithromycin, terbutaline combined with montelukast on airway function and gradient of infection in cough variant asthma children with infection
by: Xin-Xin Pei
Published: (2016-09-01)

Traditional Chinese Medicine Oral Liquids Combined With Azithromycin for Mycoplasma pneumoniae Pneumonia in Children: A Bayesian Network Meta-Analysis
by: Zhe Chen, et al.
Published: (2021-05-01)

Azithromycin Failure in Mycoplasma genitalium Urethritis
by: Catriona S. Bradshaw, et al.
Published: (2006-07-01)

MYCOPLASMA INFECTION: CLINICAL TYPES, VARIATIONS OF CLINICAL COURSE AND DIAGNOSTIC MISTAKES
by: M.S. Savenkova, et al.
Published: (2013-12-01)

Effectiveness of a multidrug therapy consisting of Ivermectin, Azithromycin, Montelukast, and Acetylsalicylic acid to prevent hospitalization and death among ambulatory COVID-19 cases in Tlaxcala, Mexico
by: René Lima-Morales, et al.
Published: (2021-04-01)

Formulation and evalution of montelukast sodium - chitosan based spray dried microspheres for pulmonary drug delivery
by: Rushi Panchal, et al.
Published: (2012-01-01)

Dynamic changes of immune function and inflammatory factors in infants with mycoplasma pneumoniae infection in different stages
by: Yan-Hong Li, et al.
Published: (2017-02-01)

Interval development of multiple sub-segmental pulmonary embolism in Mycoplasma pneumoniae bronchiolitis and pneumonia
by: Bui PV, et al.
Published: (2015-12-01)

Effects of methylprednisolone combined with montelukast on immune function and cytokines in children with recurrent Henoch-Schonlein purpura
by: Jing Dai
Published: (2018-05-01)

CLINICAL EFFECTIVENESS OF AZITHROMYCIN IN THE TREATMENT OF PNEUMONIA IN CHILDREN
by: N.D. Soroka, et al.
Published: (2006-03-01)

Azithromycin in the Treatment of Community-acquired Pneumonia in Children
by: N. I. Zryachkin, et al.
Published: (2016-04-01)

CLINICAL EFFECTIVENESS OF AZITHROMYCIN IN THE TREATMENT OF PNEUMONIA IN CHILDREN
by: N.D. Soroka, et al.
Published: (2006-01-01)

Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia
by: Xia Huang, et al.
Published: (2021-01-01)

Four-color multiplex real-time PCR assay prototype targeting azithromycin resistance mutations in Mycoplasma genitalium
by: Olivier Thellin, et al.
Published: (2019-09-01)

Place of azithromycin in the treatment of community-acquired pneumonia in children
by: S.A. Kramarov, et al.
Published: (2020-02-01)

Differences of clinical features and prognosis between Mycoplasma pneumoniae necrotizing pneumonia and non-Mycoplasma pneumoniae necrotizing pneumonia in children
by: Beilei Yang, et al.
Published: (2021-08-01)

Effect of montelukast combined with procaterol treatment on airway remodeling and inflammatory response in children with mycoplasma pneumonia
by: Jian-Mei Zhang, et al.
Published: (2016-09-01)

The study on the mechanism of Tanreqing and ambroxol combined with Azithromycin for the treatment of mycoplasma pneumonia in children
by: Li Yu, et al.
Published: (2017-02-01)

Altered chemokine profile in Refractory Mycoplasma pneumoniae pneumonia infected children
by: Yi-Chen Lee, et al.
Published: (2021-08-01)

SOME FACTORS INFLUENCING THE SURVIVAL OF MYCOPLASMA PNEUMONIAE IN AEROSOLS
by: Cozine, William Samuel, 1938-
Published: (1968)

Características clínico-radiológicas e hematológicas das pneumonias causadas pelo Mycoplasma pneumoniae
by: Letícia Alves Vervloet, et al.
Published: (2010-12-01)

Adjunctive corticosteroid therapy for inpatients with Mycoplasma pneumoniae pneumonia
by: Masato Tashiro, et al.
Published: (2017-12-01)

Morphology, ultrastructure, and functional relationships of growth and replication in Mycoplasma pneumoniae /
by: Kim, Chi Kyung
Published: (1977)

Morphology, ultrastructure, and functional relationships of growth and replication in Mycoplasma pneumoniae /
by: Kim, Chi Kyung
Published: (1977)

Assessment of serum indexes and pulmonary function after fatsoluble vitamins combined with antibiotic treatment of acute infantile mycoplasma pneumoniae infection
by: Lei Xiao
Published: (2017-02-01)

Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: a case control study
by: Young-Jin Choi, et al.
Published: (2019-08-01)

Molecular Detection of Mycoplasma Pneumoniae Using P1 Gene in Patients With Chronic Obstructive Pulmonary Syndrome
by: S Amirian, et al.
Published: (2016-08-01)